Emily Hayes and Melissa Buscheditorial@labpulse.comTrends and FinanceTechnology gives labs a hand with utilization managementA large retrospective study of test orders for almost 200,000 inpatients seen at three academic institutions -- Stanford University, the University of Michigan, and the University of California, San Francisco -- found that the best machine-learning models could have predicted with high accuracy the likelihood of normal and unnecessary results for commonly performed lab tests known to have low utility.September 15, 2019Page 1 of 1Top StoriesCancerInvivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detectionUnder the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.Regulatory ApprovalSeegene obtains IVDR certification for 30 diagnostic assaysPolicy and RegulationAdvocacy groups in letter urge FDA to develop regulations for lab-developed testsCollaborationNucleai, Adlai Nortye collaborate on biomarkers for clinical trialsSponsor ContentVisit our Molecular Diagnostics Community
